Your browser doesn't support javascript.
loading
Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes.
van Amstel, Rombout B E; Kennedy, Jason N; Scicluna, Brendon P; Bos, Lieuwe D J; Peters-Sengers, Hessel; Butler, Joe M; Cano-Gamez, Eddie; Knight, Julian C; Vlaar, Alexander P J; Cremer, Olaf L; Angus, Derek C; van der Poll, Tom; Seymour, Christopher W; van Vught, Lonneke A.
Affiliation
  • van Amstel RBE; Department of Intensive Care Medicine, Amsterdam UMC, Location University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. r.b.vanamstel@amsterdamumc.nl.
  • Kennedy JN; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands. r.b.vanamstel@amsterdamumc.nl.
  • Scicluna BP; Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Bos LDJ; Department of Applied Biomedical Science, Faculty of Health Sciences, Mater Dei Hospital, University of Malta, Msida, Malta.
  • Peters-Sengers H; Centre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta.
  • Butler JM; Department of Intensive Care Medicine, Amsterdam UMC, Location University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Cano-Gamez E; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Knight JC; Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Vlaar APJ; Epidemiology and Data Science, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Cremer OL; Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Angus DC; Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
  • van der Poll T; Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
  • Seymour CW; Department of Intensive Care Medicine, Amsterdam UMC, Location University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • van Vught LA; Laboratory of Experimental Intensive Care and Anesthesiology (L.E.I.C.A.), Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
Intensive Care Med ; 49(11): 1360-1369, 2023 11.
Article de En | MEDLINE | ID: mdl-37851064
PURPOSE: The heterogeneity in sepsis is held responsible, in part, for the lack of precision treatment. Many attempts to identify subtypes of sepsis patients identify those with shared underlying biology or outcomes. To date, though, there has been limited effort to determine overlap across these previously identified subtypes. We aimed to determine the concordance of critically ill patients with sepsis classified by four previously described subtype strategies. METHODS: This secondary analysis of a multicenter prospective observational study included 522 critically ill patients with sepsis assigned to four previously established subtype strategies, primarily based on: (i) clinical data in the electronic health record (α, ß, γ, and δ), (ii) biomarker data (hyper- and hypoinflammatory), and (iii-iv) transcriptomic data (Mars1-Mars4 and SRS1-SRS2). Concordance was studied between different subtype labels, clinical characteristics, biological host response aberrations, as well as combinations of subtypes by sepsis ensembles. RESULTS: All four subtype labels could be adjudicated in this cohort, with the distribution of the clinical subtype varying most from the original cohort. The most common subtypes in each of the four strategies were γ (61%), which is higher compared to the original classification, hypoinflammatory (60%), Mars2 (35%), and SRS2 (54%). There was no clear relationship between any of the subtyping approaches (Cramer's V = 0.086-0.456). Mars2 and SRS1 were most alike in terms of host response biomarkers (p = 0.079-0.424), while other subtype strategies showed no clear relationship. Patients enriched for multiple subtypes revealed that characteristics and outcomes differ dependent on the combination of subtypes made. CONCLUSION: Among critically ill patients with sepsis, subtype strategies using clinical, biomarker, and transcriptomic data do not identify comparable patient populations and are likely to reflect disparate clinical characteristics and underlying biology.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie grave / Sepsie Limites: Humans Langue: En Journal: Intensive Care Med Année: 2023 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie grave / Sepsie Limites: Humans Langue: En Journal: Intensive Care Med Année: 2023 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: États-Unis d'Amérique